HLA-C and neoplasm: These activated CTLs exit the lymph nodes or blood circulation, travel and infiltrate into tumor locations, detect the appropriate peptide-MHC complex on cancer cells, and subsequently destroy cancer cells and therefore lead to tumor regression [99].